Compare RACE & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RACE | IDXX |
|---|---|---|
| Founded | 1947 | 1983 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.0B | 57.1B |
| IPO Year | 2015 | 1996 |
| Metric | RACE | IDXX |
|---|---|---|
| Price | $331.32 | $562.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $477.86 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 483.6K | 470.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 13.08 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $7.91 | $10.88 |
| Revenue Next Year | $7.51 | $8.59 |
| P/E Ratio | ★ $34.59 | $42.94 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $312.51 | $471.74 |
| 52 Week High | $519.10 | $769.98 |
| Indicator | RACE | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 43.66 |
| Support Level | $328.00 | $558.15 |
| Resistance Level | $380.68 | $657.26 |
| Average True Range (ATR) | 6.52 | 17.17 |
| MACD | -3.05 | -0.02 |
| Stochastic Oscillator | 3.51 | 30.13 |
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2025, the company sold 13,640 vehicles at an average price over EUR 500,000 with more than 80% of its vehicles being sold to existing Ferrari clients. Eighty-four percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2025, the Europe, Middle East, and Africa region accounted for 49% of revenue, the Americas was 32%, mainland China, Hong Kong, and Taiwan was 7%, and the rest of Asia was 12%.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.